Anbenitamab Completed Phase 2 Trials for HER2 Positive Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04521179Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors